BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9076381)

  • 21. Acute complications of percutaneous transluminal coronary angioplasty for total occlusion.
    Plante S; Laarman G; de Feyter PJ; Samson M; Rensing BJ; Umans V; Suryapranata H; van den Brand M; Serruys PW
    Am Heart J; 1991 Feb; 121(2 Pt 1):417-26. PubMed ID: 1990745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeat percutaneous coronary angioplasty; clinical and angiographic follow-up in patients with stable or unstable angina pectoris.
    Bauters C; Lablanche JM; McFadden EP; Leroy F; Bertrand ME
    Eur Heart J; 1993 Feb; 14(2):235-9. PubMed ID: 8449200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty. A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial).
    Preisack MB; Bonan R; Meisner C; Eschenfelder V; Karsch KR
    Eur Heart J; 1998 Aug; 19(8):1232-8. PubMed ID: 9740345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease.
    Linder R; Oldgren J; Egberg N; Grip L; Larson G; Siegbahn A; Wallentin L
    Eur Heart J; 1999 Apr; 20(7):506-18. PubMed ID: 10365287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal heparinization in coronary angioplasty--how much heparin is really warranted?
    Kaluski E; Krakover R; Cotter G; Hendler A; Zyssman I; Milovanov O; Blatt A; Zimmerman E; Goldstein E; Nahman V; Vered Z
    Am J Cardiol; 2000 Apr; 85(8):953-6. PubMed ID: 10760333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Coronary angioplasty in unstable angina at rest. Influence of the degree of clinical instability on the immediate and long-term results].
    Cavallini C; Olivari Z; Risica G; Cannarozzo PP; Marton F; Grisolia EF; Giommi L; Stritoni P
    G Ital Cardiol; 1996 Jun; 26(6):647-55. PubMed ID: 8803586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a synthetic pentasaccharide, a pure factor Xa inhibitor, as an antithrombotic agent--a pilot study in the setting of coronary angioplasty.
    Vuillemenot A; Schiele F; Meneveau N; Claudel S; Donat F; Fontecave S; Cariou R; Samama MM; Bassand JP
    Thromb Haemost; 1999 Feb; 81(2):214-20. PubMed ID: 10063994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulation activity and clinical outcome in unstable coronary artery disease.
    Oldgren J; Linder R; Grip L; Siegbahn A; Wallentin L
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1059-64. PubMed ID: 11397720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
    Mombelli G; Marchetti O; Haeberli A; Straub PW
    Am Heart J; 1998 Dec; 136(6):1106-13. PubMed ID: 9842027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher recurrence rate after coronary angioplasty in unstable angina pectoris.
    Johansson SR; Ekström L; Emanuelsson H
    Angiology; 1991 Apr; 42(4):273-80. PubMed ID: 2014918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of heparin in preventing thrombin generation and thrombin activity in patients undergoing coronary intervention.
    Ragosta M; Karve M; Brezynski D; Humphries J; Sanders JM; Sarembock IJ; Gimple LW; Powers ER
    Am Heart J; 1999 Feb; 137(2):250-7. PubMed ID: 9924158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local lesion-related factors and restenosis after coronary angioplasty. Evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty.
    de Groote P; Bauters C; McFadden EP; Lablanche JM; Leroy F; Bertrand ME
    Circulation; 1995 Feb; 91(4):968-72. PubMed ID: 7850983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial.
    Topol EJ; Nicklas JM; Kander NH; Walton JA; Ellis SG; Gorman L; Pitt B
    Am J Cardiol; 1988 Sep; 62(7):368-71. PubMed ID: 2970776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.
    Hoberg E; Dietz R; Frees U; Katus HA; Rauch B; Schömig A; Schuler G; Schwarz F; Tillmanns H; Niebauer J
    Br Heart J; 1994 Mar; 71(3):254-60. PubMed ID: 8142195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous transluminal coronary angioplasty for patients with unstable angina pectoris.
    Hattori R; Yui Y; Aoyama T; Morishita H; Sakaguchi K; Susawa T; Tamaki S; Takahashi M; Shirotani M; Uchizumi H
    Jpn Circ J; 1992 Nov; 56(11):1180-3. PubMed ID: 1453543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
    Chu-fan L; Xing W; Xun H; Gui-fu W; Cheng-heng H; Zhi-min D
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators.
    Bittl JA; Strony J; Brinker JA; Ahmed WH; Meckel CR; Chaitman BR; Maraganore J; Deutsch E; Adelman B
    N Engl J Med; 1995 Sep; 333(12):764-9. PubMed ID: 7643883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early coronary angioplasty as compared with delayed coronary angioplasty in patients with high-risk unstable angina pectoris.
    Antoniucci D; Santoro GM; Bolognese L; Leoncini M; Buonamici P; Valenti R; Fazzini PF
    Coron Artery Dis; 1996 Jan; 7(1):75-80. PubMed ID: 8773437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous coronary angioscopic comparison of thrombus formation during percutaneous coronary angioplasty with ionic and nonionic low osmolality contrast media in unstable angina.
    Qureshi NR; den Heijer P; Crijns HJ
    Am J Cardiol; 1997 Sep; 80(6):700-4. PubMed ID: 9315572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.